| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.987 | 0.001 | 0.987 | Androgen agonist | 0.427 0.002 CID_154699701 | ||
| 0.983 | 0 | 0.983 | Anabolic | 0.315 0.001 CID_154699701 | ||
| 0.876 | 0.002 | 0.876 | Androgen antagonist | 0.23 0.011 CID_154699701 | ||
| 0.855 | 0.009 | 0.861 | Antiinflammatory | 0.861 0.008 CID_154699701 | CID_154699701 | |
| 0.813 | 0.002 | 0.813 | Aromatase inhibitor | 0.189 0.009 CID_154699701 | ||
| 0.78 | 0.002 | 0.78 | Estrogen agonist | 0.548 0.003 CID_154699701 | ||
| 0.782 | 0.014 | 0.892 | Transcription factor NF kappa B inhibitor | 0.892 0.007 CID_154699701 | CID_154699701 | |
| 0.704 | 0.001 | 0.704 | Progesterone agonist | 0.366 0.001 CID_154699701 | ||
| 0.717 | 0.028 | 0.762 | Apoptosis agonist | 0.762 0.021 CID_154699701 | CID_154699701 | |
| 0.689 | 0.002 | 0.689 | Progesterone antagonist | 0.082 0.011 CID_154699701 | ||
| 0.602 | 0.002 | 0.602 | Lipocortins synthesis antagonist | 0.474 0.004 CID_154699701 | ||
| 0.561 | 0.019 | 0.57 | Immunosuppressant | 0.57 0.017 CID_154699701 | CID_154699701 | |
| 0.537 | 0.013 | 0.594 | Nitric oxide antagonist | 0.594 0.01 CID_154699701 | CID_154699701 | |
| 0.477 | 0.002 | 0.477 | Glucocorticoid antagonist | 0.156 0.004 CID_154699701 | ||
| 0.448 | 0.008 | 0.448 | Sodium/bile acid cotransporter inhibitor | 0.355 0.037 CID_154699701 | ||
| 0.441 | 0.004 | 0.441 | Estrogen antagonist | 0.195 0.014 CID_154699701 | ||
| 0.446 | 0.021 | 0.446 | Hypoxia-inducible factor 1 alpha inhibitor | 0.376 0.037 CID_154699701 | ||
| 0.403 | 0.038 | 0.523 | Apoptosis antagonist | 0.523 0.017 CID_154699701 | CID_154699701 | |
| 0.366 | 0.052 | 0.366 | Aldehyde oxidase inhibitor | |||
| 0.314 | 0.003 | 0.314 | Estrogen receptor alpha agonist | 0.1 0.009 CID_154699701 | ||
| 0.304 | 0.005 | 0.304 | Estrogen receptor beta antagonist | 0.12 0.032 CID_154699701 | ||
| 0.291 | 0.004 | 0.291 | Mineralocorticoid receptor antagonist | 0.092 0.009 CID_154699701 | ||
| 0.32 | 0.037 | 0.427 | DNA synthesis inhibitor | 0.427 0.019 CID_154699701 | CID_154699701 | |
| 0.257 | 0.004 | 0.257 | Antineoplastic alkaloid | 0.201 0.014 CID_154699701 | ||
| 0.247 | 0.015 | 0.33 | Antineoplastic antibiotic | 0.33 0.008 CID_154699701 | CID_154699701 | |
| 0.227 | 0.004 | 0.227 | Estrogen receptor beta agonist | 0.152 0.007 CID_154699701 | ||
| 0.254 | 0.042 | 0.407 | Hepatoprotectant | 0.407 0.013 CID_154699701 | CID_154699701 | |
| 0.253 | 0.049 | 0.265 | Anesthetic general | 0.265 0.044 CID_154699701 | CID_154699701 | |
| 0.216 | 0.02 | 0.216 | Arachidonic acid antagonist | |||
| 0.212 | 0.017 | 0.235 | Microtubule formation inhibitor | 0.235 0.013 CID_154699701 | CID_154699701 | |
| 0.227 | 0.032 | 0.258 | Lipid peroxidase inhibitor | 0.258 0.025 CID_154699701 | CID_154699701 | |
| 0.258 | 0.071 | 0.388 | Tumour necrosis factor alpha release inhibitor | 0.388 0.029 CID_154699701 | CID_154699701 | |
| 0.211 | 0.028 | 0.211 | Acetylcholine antagonist | |||
| 0.22 | 0.037 | 0.437 | Diuretic | 0.437 0.011 CID_154699701 | CID_154699701 | |
| 0.211 | 0.029 | 0.211 | Cholinergic antagonist | |||
| 0.305 | 0.132 | 0.652 | Antibacterial | 0.652 0.013 CID_154699701 | CID_154699701 | |
| 0.2 | 0.036 | 0.2 | Bone formation stimulant | 0.153 0.056 CID_154699701 | ||
| 0.185 | 0.027 | 0.185 | Farnesoid X receptor antagonist | 0.133 0.077 CID_154699701 | ||
| 0.155 | 0.011 | 0.155 | Estrogen receptor alpha antagonist | |||
| 0.188 | 0.046 | 0.293 | Interferon gamma antagonist | 0.293 0.021 CID_154699701 | CID_154699701 | |
| 0.174 | 0.032 | 0.174 | Acetylcholine muscarinic antagonist | |||
| 0.232 | 0.094 | 0.463 | Antioxidant | 0.463 0.025 CID_154699701 | CID_154699701 | |
| 0.143 | 0.007 | 0.143 | 5-Alpha-reductase inhibitor | 0.038 0.025 CID_154699701 | ||
| 0.189 | 0.072 | 0.189 | P-glycoprotein inhibitor | 0.158 0.105 CID_154699701 | ||
| 0.121 | 0.007 | 0.121 | Aldosterone antagonist | |||
| 0.132 | 0.021 | 0.132 | Inducible nitric-oxide synthase inhibitor | |||
| 0.302 | 0.192 | 0.316 | Caspase 9 stimulant | 0.316 0.177 CID_154699701 | CID_154699701 | |
| 0.114 | 0.004 | 0.114 | Lipocortins synthesis agonist | 0.1 0.005 CID_154699701 | ||
| 0.123 | 0.015 | 0.136 | Na+ K+ transporting ATPase inhibitor | 0.136 0.009 CID_154699701 | CID_154699701 | |
| 0.158 | 0.067 | 0.158 | Acetylcholine M1 receptor antagonist | |||
| 0.076 | 0.003 | 0.076 | Glucocorticoid agonist | 0.031 0.006 CID_154699701 | ||
| 0.099 | 0.033 | 0.111 | Glycine receptor antagonist | 0.111 0.024 CID_154699701 | CID_154699701 | |
| 0.067 | 0.008 | 0.067 | Parathyroid hormone antagonist | 0.046 0.029 CID_154699701 | ||
| 0.059 | 0.006 | 0.059 | Estrone sulfatase inhibitor | |||
| 0.059 | 0.011 | 0.059 | RNA-directed RNA polymerase stimulant | 0.033 0.019 CID_154699701 | ||
| 0.045 | 0.003 | 0.045 | Corticosteroid-like | 0.036 0.005 CID_154699701 | ||
| 0.033 | 0.004 | 0.033 | Progesterone receptor B antagonist | |||
| 0.057 | 0.032 | 0.057 | Acetylcholine M2 receptor agonist | |||
| 0.028 | 0.008 | 0.028 | Vitamin D receptor antagonist | 0.024 0.011 CID_154699701 | ||
| 0.07 | 0.055 | 0.07 | Glycine receptor agonist | 0.068 0.059 CID_154699701 | ||
| 0.151 | 0.136 | 0.218 | Hypolipemic | 0.218 0.083 CID_154699701 | CID_154699701 | |
| 0.025 | 0.011 | 0.025 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.033 | 0.021 | 0.033 | Estrogen-related receptor beta antagonist | |||
| 0.091 | 0.083 | 0.166 | Monophenol monooxygenase inhibitor | 0.166 0.041 CID_154699701 | CID_154699701 | |
| 0.043 | 0.037 | 0.05 | Microtubule stabilization | 0.05 0.028 CID_154699701 | CID_154699701 | |
| 0.032 | 0.028 | 0.032 | HMG CoA reductase inhibitor | |||
| 0.039 | 0.056 | 0.113 | Protein 50S ribosomal subunit inhibitor | 0.113 0.01 CID_154699701 | CID_154699701 | |
| 0.101 | 0.12 | 0.16 | Protein kinase stimulant | 0.16 0.061 CID_154699701 | CID_154699701 | |
| 0.13 | 0.151 | 0.208 | Non-steroidal antiinflammatory agent | 0.208 0.065 CID_154699701 | CID_154699701 | |
| 0.121 | 0.145 | 0.141 | Interleukin 6 antagonist | 0.141 0.103 CID_154699701 | CID_154699701 | |
| 0.084 | 0.11 | 0.205 | Alkylator | 0.205 0.025 CID_154699701 | CID_154699701 | |
| 0.004 | 0.033 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 CID_154699701 | CID_154699701 | |
| 0.114 | 0.148 | 0.145 | Melanin inhibitor | 0.145 0.089 CID_154699701 | CID_154699701 | |
| 0.014 | 0.053 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 CID_154699701 | CID_154699701 | |
| 0.172 | 0.216 | 0.597 | Antithrombotic | 0.597 0.017 CID_154699701 | CID_154699701 | |
| 0.012 | 0.057 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.014 CID_154699701 | CID_154699701 | |
| 0.071 | 0.117 | 0.112 | Protein-tyrosine phosphatase 1B inhibitor | 0.112 0.068 CID_154699701 | CID_154699701 | |
| 0.18 | 0.227 | 0.354 | Interleukin 2 agonist | 0.354 0.044 CID_154699701 | CID_154699701 | |
| 0.063 | 0.128 | 0.115 | Transcription factor NF kappa B stimulant | 0.115 0.028 CID_154699701 | CID_154699701 | |
| 0.093 | 0.184 | 0.18 | NOS3 expression enhancer | 0.18 0.05 CID_154699701 | CID_154699701 | |
| 0.113 | 0.203 | 0.355 | Free radical scavenger | 0.355 0.038 CID_154699701 | CID_154699701 | |
| 0.031 | 0.125 | 0.059 | Glucose-6-phosphate translocase inhibitor | 0.059 0.024 CID_154699701 | CID_154699701 | |
| 0.049 | 0.145 | 0.12 | Topoisomerase I inhibitor | 0.12 0.056 CID_154699701 | CID_154699701 | |
| 0.067 | 0.165 | 0.131 | Toll-Like receptor 4 antagonist | 0.131 0.034 CID_154699701 | CID_154699701 | |
| 0.083 | 0.182 | 0.124 | Protein-tyrosine phosphatase inhibitor | 0.124 0.108 CID_154699701 | CID_154699701 | |
| 0.077 | 0.191 | 0.458 | Angiogenesis stimulant | 0.458 0.015 CID_154699701 | CID_154699701 | |
| 0.02 | 0.138 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 CID_154699701 | CID_154699701 | |
| 0.126 | 0.267 | 0.318 | Cholesterol antagonist | 0.318 0.08 CID_154699701 | CID_154699701 | |
| 0.102 | 0.262 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.048 CID_154699701 | CID_154699701 | |
| 0.015 | 0.188 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.015 CID_154699701 | CID_154699701 | |
| 0.077 | 0.272 | 0.341 | Immunostimulant | 0.341 0.067 CID_154699701 | CID_154699701 | |
| 0.033 | 0.266 | 0.105 | Topoisomerase II inhibitor | 0.105 0.082 CID_154699701 | CID_154699701 | |
| 0.107 | 0.381 | 0.3 | Peptidyltransferase inhibitor | 0.3 0.024 CID_154699701 | CID_154699701 | |
| 0.055 | 0.352 | 0.265 | Platelet adhesion inhibitor | 0.265 0.045 CID_154699701 | CID_154699701 | |
| 0.044 | 0.341 | 0.127 | Cyclooxygenase 3 inhibitor | 0.127 0.069 CID_154699701 | CID_154699701 | |
| 0.05 | 0.405 | 0.182 | Vasodilator | 0.182 0.12 CID_154699701 | CID_154699701 | |
| 0.009 | 0.388 | 0.193 | Selectin antagonist | 0.193 0.012 CID_154699701 | CID_154699701 | |
| 0.072 | 0.47 | 0.201 | Immunomodulator | 0.201 0.163 CID_154699701 | CID_154699701 | |
| 0.092 | 0.497 | 0.5 | Cyclophilin D inhibitor | 0.5 0.05 CID_154699701 | CID_154699701 | |
| 0.028 | 0.505 | 0.226 | Platelet antagonist | 0.226 0.084 CID_154699701 | CID_154699701 | |
| 0.033 | 0.679 | 0.3 | Hypoglycemic | 0.3 0.053 CID_154699701 | CID_154699701 | |
| 0.009 | 0.766 | 0.13 | Thrombolytic | 0.13 0.099 CID_154699701 | CID_154699701 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |